Everest (EG)
Market Price (12/22/2025): $331.895 | Market Cap: $13.7 BilSector: Financials | Industry: Reinsurance
Everest (EG)
Market Price (12/22/2025): $331.895Market Cap: $13.7 BilSector: FinancialsIndustry: Reinsurance
Investment Highlights
Why It Matters
Which of these 2 stories sounds closer for this stock?
1. Generates cash flow
The stock generated 4% or more of the share price (called cash flow yield), and shows moderate 10-15% or more growth.
2. Riding a trend
Think Tesla during the pandemic of 2020 when EVs were riding a cultural high, or Nvidia in the current AI boom, or even Figma. These companies don’t have enough yield, or, enough growth, or both - however - they are riding a trend. They have momentum. These can be more volatile - they don’t have the floor of strong cash flow
| Attractive yieldTotal YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 6.5%, Dividend Yield is 2.5%, FCF Yield is 31% | Weak multi-year price returns2Y Excs Rtn is -48%, 3Y Excs Rtn is -63% | Weak revenue growthRev Chg QQuarterly Revenue Change % is -0.1% |
| Cash is significant % of market capNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -121% | Key risksEG key risks include [1] substantial reserve strengthening required for poorly underwritten legacy insurance policies, Show more. | |
| Attractive cash flow generationCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 24%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 24%, CFO LTM is 4.2 Bil, FCF LTM is 4.2 Bil | ||
| Low stock price volatilityVol 12M is 26% | ||
| Megatrend and thematic driversMegatrends include Global Risk & Resilience. Themes include Climate Risk Adaptation, Cyber Risk Insurance, and Specialty & Complex Risk Underwriting. |
| Attractive yieldTotal YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 6.5%, Dividend Yield is 2.5%, FCF Yield is 31% |
| Cash is significant % of market capNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -121% |
| Attractive cash flow generationCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 24%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 24%, CFO LTM is 4.2 Bil, FCF LTM is 4.2 Bil |
| Low stock price volatilityVol 12M is 26% |
| Megatrend and thematic driversMegatrends include Global Risk & Resilience. Themes include Climate Risk Adaptation, Cyber Risk Insurance, and Specialty & Complex Risk Underwriting. |
| Weak multi-year price returns2Y Excs Rtn is -48%, 3Y Excs Rtn is -63% |
| Weak revenue growthRev Chg QQuarterly Revenue Change % is -0.1% |
| Key risksEG key risks include [1] substantial reserve strengthening required for poorly underwritten legacy insurance policies, Show more. |
Valuation, Metrics & Events
EG Stock
Why The Stock Moved
Qualitative Assessment
AI Generated Analysis | Feedback
Here are key points highlighting why Everest's (EG) stock moved by -1.9% for the approximate time period from August 31, 2025, to December 22, 2025, based on available information:
1. Significant Underperformance in Q3 2025 Earnings: Everest Group reported a substantial decline in net income and operating income for the third quarter of 2025 compared to the prior year. Net income was $255 million, roughly half of the $509 million reported in Q3 2024, and net operating income fell to $316 million from $630 million. The operating income per share of $7.54 also missed the Zacks Consensus Estimate by 43.7%.
2. Unfavorable Prior-Year Reserve Development: The company experienced significant unfavorable development of prior-year loss reserves totaling $478 million in Q3 2025, which increased the group's combined ratio by 12.4 points. This was largely concentrated in the insurance segment, where U.S. casualty reserves for accident years 2022-2024 were strengthened by $361 million due to elevated loss experience in excess casualty and U.S. liability lines. This followed a $1.7 billion strengthening of U.S. casualty reserves for the full year 2024, reflecting ongoing challenges with social inflation and portfolio concentrations.
Stock Movement Drivers
Return vs. Risk
Price Returns Compared
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| EG Return | -13% | 20% | 24% | 9% | 5% | -6% | 38% |
| Peers Return | -18% | 9% | 13% | 25% | 23% | 7% | 65% |
| S&P 500 Return | 16% | 27% | -19% | 24% | 23% | 16% | 112% |
Monthly Win Rates [3] | |||||||
| EG Win Rate | 50% | 58% | 58% | 75% | 50% | 50% | |
| Peers Win Rate | 52% | 57% | 50% | 63% | 55% | 55% | |
| S&P 500 Win Rate | 58% | 75% | 42% | 67% | 75% | 73% | |
Max Drawdowns [4] | |||||||
| EG Max Drawdown | -41% | -10% | -9% | 0% | -0% | -14% | |
| Peers Max Drawdown | -52% | -11% | -16% | -4% | -1% | -13% | |
| S&P 500 Max Drawdown | -31% | -1% | -25% | -1% | -2% | -15% | |
[1] Cumulative total returns since the beginning of 2020
[2] Peers: RGA, RNR, MTG, GLRE, EG.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 12/19/2025 (YTD)
How Low Can It Go
| Event | EG | S&P 500 |
|---|---|---|
| 2022 Inflation Shock | ||
| % Loss | -20.0% | -25.4% |
| % Gain to Breakeven | 24.9% | 34.1% |
| Time to Breakeven | 32 days | 464 days |
| 2020 Covid Pandemic | ||
| % Loss | -44.6% | -33.9% |
| % Gain to Breakeven | 80.4% | 51.3% |
| Time to Breakeven | 638 days | 148 days |
| 2018 Correction | ||
| % Loss | -24.4% | -19.8% |
| % Gain to Breakeven | 32.2% | 24.7% |
| Time to Breakeven | 396 days | 120 days |
| 2008 Global Financial Crisis | ||
| % Loss | -48.6% | -56.8% |
| % Gain to Breakeven | 94.4% | 131.3% |
| Time to Breakeven | 1,330 days | 1,480 days |
Compare to RGA, RNR, MTG, GLRE, EG
In The Past
Everest's stock fell -20.0% during the 2022 Inflation Shock from a high on 4/1/2022. A -20.0% loss requires a 24.9% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth over time.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
Latest Trefis Analyses
Trade Ideas
Select past ideas related to EG. For more, see Trefis Trade Ideas.
| Date | Ticker | Company | Category | Trade Strategy | 6M Fwd Rtn | 12M Fwd Rtn | 12M Max DD |
|---|---|---|---|---|---|---|---|
| 11212025 | WU | Western Union | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | 13.5% | 13.5% | -0.4% |
| 11212025 | COIN | Coinbase Global | Monopoly | MY | Getting CheaperMonopoly-Like with P/S DeclineLarge cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple | 2.0% | 2.0% | -0.5% |
| 11142025 | PYPL | PayPal | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | -4.8% | -4.8% | -7.5% |
| 11142025 | V | Visa | Monopoly | MY | Getting CheaperMonopoly-Like with P/S DeclineLarge cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple | 5.8% | 5.8% | -2.7% |
| 11072025 | WD | Walker & Dunlop | Dip Buy | DB | P/E OPMDip Buy with Low PE and High MarginBuying dips for companies with tame PE and meaningfully high operating margin | -12.1% | -12.1% | -12.1% |
| 03312020 | EG | Everest | Dip Buy | DB | Growth | FCF YieldDip Buy with Growth and High Free Cash Flow YieldBuying dips for companies with growth, and significant free cash flow yield (FCF / Market Cap) | 5.4% | 32.4% | -16.0% |
| Date | Ticker | Company | Category | Trade Strategy | 6M Fwd Rtn | 12M Fwd Rtn | 12M Max DD |
|---|---|---|---|---|---|---|---|
| 11212025 | WU | Western Union | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | 13.5% | 13.5% | -0.4% |
| 11212025 | COIN | Coinbase Global | Monopoly | MY | Getting CheaperMonopoly-Like with P/S DeclineLarge cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple | 2.0% | 2.0% | -0.5% |
| 11142025 | PYPL | PayPal | Dip Buy | DB | FCFY OPMDip Buy with High FCF Yield and High MarginBuying dips for companies with high FCF yield and meaningfully high operating margin | -4.8% | -4.8% | -7.5% |
| 11142025 | V | Visa | Monopoly | MY | Getting CheaperMonopoly-Like with P/S DeclineLarge cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple | 5.8% | 5.8% | -2.7% |
| 11072025 | WD | Walker & Dunlop | Dip Buy | DB | P/E OPMDip Buy with Low PE and High MarginBuying dips for companies with tame PE and meaningfully high operating margin | -12.1% | -12.1% | -12.1% |
| 03312020 | EG | Everest | Dip Buy | DB | Growth | FCF YieldDip Buy with Growth and High Free Cash Flow YieldBuying dips for companies with growth, and significant free cash flow yield (FCF / Market Cap) | 5.4% | 32.4% | -16.0% |
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons for Everest
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 205.70 |
| Mkt Cap | 12.8 |
| Rev LTM | 12,103 |
| Op Inc LTM | - |
| FCF LTM | 3,989 |
| FCF 3Y Avg | 3,340 |
| CFO LTM | 3,989 |
| CFO 3Y Avg | 3,340 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | 2.2% |
| Rev Chg 3Y Avg | 12.2% |
| Rev Chg Q | -0.7% |
| QoQ Delta Rev Chg LTM | -0.2% |
| Op Mgn LTM | - |
| Op Mgn 3Y Avg | - |
| QoQ Delta Op Mgn LTM | - |
| CFO/Rev LTM | 24.3% |
| CFO/Rev 3Y Avg | 29.6% |
| FCF/Rev LTM | 24.3% |
| FCF/Rev 3Y Avg | 29.6% |
Valuation
| Median | |
|---|---|
| Name | |
| Mkt Cap | 12.8 |
| P/S | 0.8 |
| P/EBIT | 8.4 |
| P/E | 9.0 |
| P/CFO | 3.2 |
| Total Yield | 8.1% |
| Dividend Yield | 1.7% |
| FCF Yield 3Y Avg | 27.9% |
| D/E | 0.2 |
| Net D/E | -0.8 |
Returns
| Median | |
|---|---|
| Name | |
| 1M Rtn | 8.4% |
| 3M Rtn | 10.8% |
| 6M Rtn | 6.1% |
| 12M Rtn | 3.8% |
| 3Y Rtn | 53.0% |
| 1M Excs Rtn | 3.7% |
| 3M Excs Rtn | 8.6% |
| 6M Excs Rtn | -8.6% |
| 12M Excs Rtn | -12.8% |
| 3Y Excs Rtn | -13.5% |
FDA Approved Drugs Data
Expand for More| Post-Approval Fwd Returns | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| FDA App # | Brand Name | Generic Name | Dosage Form | FDA Approval | 3M Rtn | 6M Rtn | 1Y Rtn | 2Y Rtn | Total Rtn |
| ANDA218755 | PALIPERIDONE | paliperidone | tablet, extended release | 9042025 | -8.6% | -3.4% | -3.4% | -3.4% | -3.4% |
Returns Analyses
Earnings Returns History
Expand for More| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 10/27/2025 | -11.4% | -8.9% | -8.7% |
| 7/30/2025 | 1.0% | -1.2% | 2.2% |
| 4/30/2025 | -6.0% | -4.7% | -2.7% |
| 2/3/2025 | -1.0% | -3.4% | 3.9% |
| 10/30/2024 | -6.4% | -3.5% | 2.5% |
| 7/31/2024 | -6.2% | -8.2% | -0.6% |
| 4/29/2024 | -0.7% | 2.7% | 4.2% |
| 2/7/2024 | -7.7% | -3.4% | -4.2% |
| ... | |||
| SUMMARY STATS | |||
| # Positive | 11 | 14 | 11 |
| # Negative | 13 | 10 | 13 |
| Median Positive | 2.0% | 3.3% | 4.4% |
| Median Negative | -3.4% | -3.5% | -1.8% |
| Max Positive | 7.2% | 14.3% | 38.5% |
| Max Negative | -11.4% | -8.9% | -19.7% |
SEC Filings
Expand for More| Report Date | Filing Date | Filing |
|---|---|---|
| 9302025 | 10312025 | 10-Q 9/30/2025 |
| 6302025 | 8012025 | 10-Q 6/30/2025 |
| 3312025 | 5022025 | 10-Q 3/31/2025 |
| 12312024 | 2272025 | 10-K 12/31/2024 |
| 9302024 | 11052024 | 10-Q 9/30/2024 |
| 6302024 | 8022024 | 10-Q 6/30/2024 |
| 3312024 | 5032024 | 10-Q 3/31/2024 |
| 12312023 | 2282024 | 10-K 12/31/2023 |
| 9302023 | 11012023 | 10-Q 9/30/2023 |
| 6302023 | 8032023 | 10-Q 6/30/2023 |
| 3312023 | 5042023 | 10-Q 3/31/2023 |
| 12312022 | 2242023 | 10-K 12/31/2022 |
| 9302022 | 11032022 | 10-Q 9/30/2022 |
| 6302022 | 8042022 | 10-Q 6/30/2022 |
| 3312022 | 5052022 | 10-Q 3/31/2022 |
| 12312021 | 2282022 | 10-K 12/31/2021 |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |